Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening

References

• Jack CRJr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013;12(2):207-16
   PubMed Web of Science ®Google Scholar
• Kansara S, Trivedi A, Chen S, et al. Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed? J Neural Transm 2013;120(1):197-210
   PubMedGoogle Scholar
• Sheinerman KS, Umansky SR. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 2013;7:150
   PubMed Web of Science ®Google Scholar
• Snyder EM, Olin J, David FS. Maximizing the value of diagnostics in Alzheimer’s disease drug development. Nat Rev Drug Discov 2012;11:183-4
   PubMedGoogle Scholar
• Friedrich MJ. Researchers test strategies to prevent Alzheimer disease. JAMA 2014;311(16):1596-8
   PubMed Web of Science ®Google Scholar
• Sperling RA, Rentz DM, Johnson KA, et al. The A4 study: stopping AD before symptoms begin? Sci Transl Med 2014;6(228):228fs13
   PubMed Web of Science ®Google Scholar
• Becker RE, Greig NH, Giacobini E, et al. A new roadmap for drug development for Alzheimer’s disease. Nat Rev Drug Discov 2014;13(2):156
   PubMed Web of Science ®Google Scholar
• Caldas C. Cancer sequencing unravels clonal evolution. Nat Biotechnol 2012;30:408-10
   PubMedGoogle Scholar
• Ashworth A, Lord CJ, Reis-Filho JS. Genetic interactions in cancer progression and treatment. Cell 2011;145(1):30-8
   PubMed Web of Science ®Google Scholar
• Chen G, Davies MA. Targeted therapy resistance mechanisms and therapeutic implications in melanoma. Hematol Oncol Clin North Am 2014;28(3):523-36
   PubMed Web of Science ®Google Scholar
• Lamond NW, Younis T. Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations. Int J Women Health 2014;6:509-21
   PubMedGoogle Scholar
• Hohla F, Winder T, Greil R, et al. Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives. World J Gastroenterol 2014;20(20):6102-12
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64(2):104-17
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64(1):9-29
   PubMed Web of Science ®Google Scholar
• Moyer VA; US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012;156(12):880-91
   PubMedGoogle Scholar
• Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012;9:850-9
   PubMed Web of Science ®Google Scholar
• Lawrie CH. MicroRNAs: a brief introduction. In: MicroRNA in Medicine. Lawrie CH, Editor) Wiley-Blackwell; USA: 2014. 2-24
   Google Scholar
• Hoy AM, Buck AH. Extracellular small RNAs: what, where, why? Biochem Soc Trans 2012;40:886-90
   PubMedGoogle Scholar
• Beuvink I, Kolb FA, Budach W, et al. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res 2007;35:e52
   Google Scholar
• Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007;8:166-85
   PubMed Web of Science ®Google Scholar
• Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-14
   PubMed Web of Science ®Google Scholar
• Castellano L, Stebbing J. Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues. Nucleic Acids Res 2013;41:3339-51
   PubMed Web of Science ®Google Scholar
• He M, Liu Y, Wang X, et al. Cell-type-based analysis of microRNA profiles in the mouse brain. Neuron 2012;73:35-48
   PubMed Web of Science ®Google Scholar
• Schratt G. microRNAs at the synapse. Nat Rev Neurosci 2009;10:842-9
   PubMed Web of Science ®Google Scholar
• Natera-Naranjo O, Aschrafi A, Gioio AE, Kaplan BB. Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons. RNA 2010;16:1516-29
   PubMed Web of Science ®Google Scholar
• Wu D, Raafat M, Pak E, et al. MicroRNA machinery responds to peripheral nerve lesion in an injury-regulated pattern. Neuroscience 2011;190:386-97
   PubMed Web of Science ®Google Scholar
• Pichardo-Casas I, Goff LA, Swerdel MR, et al. Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res 2012;1436:20-33
   PubMed Web of Science ®Google Scholar
• Kosaka N, Yoshioka Y, Hagiwara K, et al. Trash or treasure: extracellular microRNAs and cell-to-cell communication. Front Genet 2013;4:173
   PubMedGoogle Scholar
• Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012;37:460-5
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang K, Fan G, Li J. Identification of circulating microRNAs as biomarkers in cancers: what have we got? Clin Chem Lab Med 2012;50(12):2121-6
   PubMedGoogle Scholar
• Zandberga E, Kozirovskis V, Ābols A, et al. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 2013;52(4):356-69
   PubMed Web of Science ®Google Scholar
• Duttagupta R, Jiang R, Gollub J, et al. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011;6:e20769
   PubMed Web of Science ®Google Scholar
• Pigati L, Yaddanapudi SC, Iyengar R, et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010;5(10):e13515
   PubMed Web of Science ®Google Scholar
• Palma J, Yaddanapudi SC, Pigati L, et al. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 2012;40(18):9125-38
   PubMed Web of Science ®Google Scholar
• Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 2012;40(21):10937-49
   PubMed Web of Science ®Google Scholar
• Williams Z, Ben-Dov IZ, Elias R, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci USA 2013;110(11):4255-60
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 2014;18:371-90
   PubMed Web of Science ®Google Scholar
• Cuk K, Zucknick M, Heil J, et al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 2013;132:1602-12
   PubMed Web of Science ®Google Scholar
• Haider BA, Baras AS, McCall MN, et al. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One 2014;9:e89565
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012;5:492-7
   PubMed Web of Science ®Google Scholar
• Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011;108(9):3713-18
   PubMed Web of Science ®Google Scholar
• Cuk K, Zucknick M, Madhavan D, et al. Plasma microRNA panel for minimally invasive detection of breast cancer. PLoS One 2013;8(10):e76729
   PubMed Web of Science ®Google Scholar
• Zhu J, Zheng Z, Wang J, et al. Different miRNA expression profiles between human breast cancer tumors and serum. Front Genet 2014;5:149
   PubMed Web of Science ®Google Scholar
• Sheinerman KS, Tsivinsky VG, Crawford F, et al. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 2012;4(9):590-605
   PubMedGoogle Scholar
• Sheinerman KS, Tsivinsky VG, Abdullah L, et al. Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging (Albany NY) 2013;5(12):925-38
   PubMedGoogle Scholar
• Sheinerman KS, Tsivinsky VG, Umansky SR. Analysis of organ-enriched microRNAs in plasma as an approach to development of universal screening test: feasibility study. J Transl Med 2013;11:304
   PubMedGoogle Scholar
• Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010;50(4):298-301
   PubMed Web of Science ®Google Scholar
• Sanders I, Holdenrieder S, Walgenbach-Brünagel G, et al. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol 2012;19(11):1017-25
   PubMed Web of Science ®Google Scholar
• Lardizábal MN, Nocito AL, Daniele SM, et al. Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in rat models of hepatotoxicity. PLoS One 2012;7(5):e36323
   Google Scholar
• Katsuura S, Kuwano Y, Yamagishi N, et al. MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci Lett 2012;516(1):79-84
   PubMed Web of Science ®Google Scholar
• Hennessey PT, Sanford T, Choudhary A, et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012;7(2):e32307
   PubMed Web of Science ®Google Scholar
• Matthaei H, Wylie D, Lloyd MB, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012;18(17):4713-24
   PubMed Web of Science ®Google Scholar
• Sheinerman K, Tsivinsky V, Abdullah L, et al. Detection and differentiation of Mild Cognitive Impairment, Alzheimer’s and Parkinson’s diseases by analysis of brain-enriched microRNAs in plasma. Abstracts of AAIC Alzheimer Demen 2014; In Press
   Google Scholar
• Stafford P, Cichacz Z, Woodbury NW, et al. Immunosignature system for diagnosis of cancer. Proc Natl Acad Sci USA 2014;111(30):E3072-80
   PubMed Web of Science ®Google Scholar
• Warren AD, Kwong GA, Wood DK, et al. Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc Natl Acad Sci USA 2014;111(10):3671-6
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107(5):677-84
   PubMed Web of Science ®Google Scholar
• Widera C, Gupta SK, Lorenzen JM, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51(5):872-5
   PubMed Web of Science ®Google Scholar
• Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010;31(6):659-66
   PubMed Web of Science ®Google Scholar
• D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31(22):2765-73
   PubMed Web of Science ®Google Scholar
• Devaux Y, Vausort M, Goretti E, et al. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 2012;58(3):559-67
   PubMed Web of Science ®Google Scholar
• Goren Y, Kushnir M, Zafrir B, et al. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012;14:147-54
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106(11):4402-7
   PubMed Web of Science ®Google Scholar
• Li LM, Hu ZB, Zhou ZX, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010;70(23):9798-807
   PubMed Web of Science ®Google Scholar
• Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011;6(8):e23937
   PubMed Web of Science ®Google Scholar
• Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011;29(36):4781-8
   PubMed Web of Science ®Google Scholar
• Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012;56(5):1946-57
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010;56:1830-8
   PubMed Web of Science ®Google Scholar
• Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011;91(4):579-87
   PubMed Web of Science ®Google Scholar
• Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012;130:1620-8
   PubMed Web of Science ®Google Scholar
• Akbas F, Coskunpinar E, Aynaci E, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res 2012;38:286-94
   PubMed Web of Science ®Google Scholar
• Zahm AM, Thayu M, Hand NJ, et al. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011;53:26-33
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102(7):1174-9
   PubMed Web of Science ®Google Scholar
• Cai H, Yuan Y, Hao YF, et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol 2013;30(1):452
   PubMed Web of Science ®Google Scholar
• Nielsen LB, Wang C, Sørensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012;2012:896362
   PubMedGoogle Scholar
• Weng H, Shen C, Hirokawa G, et al. Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 2011;32:135-41
   PubMed Web of Science ®Google Scholar
• Mizuno H, Nakamura A, Aoki Y, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 2011;6:e18388
   PubMed Web of Science ®Google Scholar
• Perfetti A, Greco S, Bugiardini E, et al. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord 2014;24(6):509-15
   PubMed Web of Science ®Google Scholar
• Roth C, Rack B, Müller V, et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010;12:R90
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Kerin MJ. Circulating microRNAs: promising breast cancer Biomarkers. Breast Cancer Res 2011;13:402
   PubMedGoogle Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18
   PubMed Web of Science ®Google Scholar
• Lodes MJ, Caraballo M, Suciu D, et al. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009;4:e6229
   PubMed Web of Science ®Google Scholar
• Shen J, Hruby GW, McKiernan JM, et al. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012;72(13):1469-77
   PubMed Web of Science ®Google Scholar
• Chabre O, Libé R, Assié G, et al. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr Relat Cancer 2013;20(4):579-94
   PubMed Web of Science ®Google Scholar
• Tölle A, Jung M, Rabenhorst S, et al. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Oncol Rep 2013;30(4):1949-56
   PubMed Web of Science ®Google Scholar
• Jiang X, Du L, Wang L, et al. Serum microRNA expression signatures identified from genome-wide miRNA profiling serve as novel non-invasive biomarkers for diagnosis and recurrence of bladder cancer. Int J Cancer 2014;10.1002/ijc.29041. [Epub ahead of print]
   Google Scholar
• Zheng H, Zhang L, Zhao Y, et al. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One 2013;8(11):e77853
   PubMed Web of Science ®Google Scholar